Compounded vs Brand Semaglutide: Safety, Legality, and Cost in 2026

Reviewed by Sydney Duong, RD, GLPeak Clinical Lead · Last updated 2026-06-17

Quick answer: The FDA removed semaglutide from the official shortage list, which ended most compounding pharmacies' legal authority to mass-produce it. Compounded semaglutide is not FDA-approved, is not regulated for sterility or potency, and is no longer broadly legal in 2026. Brand Ozempic and Wegovy remain the safest, regulated option — supplemented by NovoCare cash-pay or manufacturer savings cards for cost.

Why compounded semaglutide existed

Federal law lets compounding pharmacies make a non-branded version of a drug while it's on the FDA's official shortage list. Semaglutide was on that list from 2022 through 2024, which is when telehealth clinics shipped compounded vials at a fraction of brand pricing.

Once a drug comes off the shortage list, most compounding stops. Section 503A and 503B pharmacies have a narrow personalization carve-out (a documented clinical reason a specific patient needs a non-standard formulation), but mass-market compounding for cost reasons is no longer allowed.

Safety differences

Brand semaglutide is FDA-approved, GMP-manufactured, and lot-tested for sterility and potency.
Compounded semaglutide is not FDA-approved. Quality varies by pharmacy.
"Semaglutide salts" (semaglutide sodium, semaglutide acetate) are explicitly not the same molecule as branded semaglutide — the FDA has warned against them.
Compounded vials have higher reported rates of dosing errors and contamination events.

Cost comparison in 2026

Brand Ozempic with commercial insurance + savings card: as low as $25/month.
Brand Wegovy with commercial insurance + savings card: as low as $25/month.
NovoCare cash-pay (no insurance): roughly $499/month for Wegovy.
Compounded semaglutide (where legally still available): roughly $150–$300/month, but quality and legality vary.

Frequently asked questions

Can my telehealth clinic still ship compounded semaglutide?

Most cannot, as of 2026. A narrow personalization exception exists, but mass-market compounded shipments are largely no longer legal. Confirm any clinic offering it is operating within FDA guidance.

Is compounded tirzepatide the same situation?

Yes — tirzepatide also came off the shortage list, ending most compounding. Eli Lilly now offers self-pay Zepbound vials through LillyDirect as an FDA-approved alternative.

What if I was already on compounded semaglutide?

Talk to a prescriber about transitioning to brand Ozempic, Wegovy, or self-pay Zepbound. Don't abruptly stop a GLP-1 if you're mid-treatment without a plan.

Related GLPeak tools

Educational only — not medical advice. Consult your prescriber before changing any medication.